Not applicableLooking for participantsNCT07186244What this trial is testingPrevention ICONA Dedicated EnsembleWho this might be right forPrEPPrEP Adherence MonitoringHIV+3 more Fondazione ICONA 5,000
Not applicableStudy completedNCT01362634What this trial is testingA Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIVWho this might be right forHIV InfectionSubstance Abuse Nova Southeastern University 750
Testing effectiveness (Phase 2)Study completedNCT02578706What this trial is testingTargeting Platelets in Chronic HIV InfectionWho this might be right forHIV-1 Infection Icahn School of Medicine at Mount Sinai 27
Not applicableStudy completedNCT00386971What this trial is testingEffects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAARTWho this might be right forHyperlipidemiaHIV Infections University of California, Davis 13
Testing effectiveness (Phase 2)Study completedNCT00080106What this trial is testingEffectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 114
Large-scale testing (Phase 3)Study completedNCT00119106What this trial is testingBangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, ThailandWho this might be right forHIV Infections Centers for Disease Control and Prevention 2,413
Testing effectiveness (Phase 2)Study completedNCT00257621What this trial is testingGW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected AdultsWho this might be right forInfection, Human Immunodeficiency Virus IHIV Infection ViiV Healthcare 30
Post-approval studies (Phase 4)Study completedNCT00630734What this trial is testingGenetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and PravastatinWho this might be right forHIV InfectionsHyperlipidemia University of Colorado, Denver 32
Not applicableUnknownNCT03860116What this trial is testingEvaluation of a Smart Phone App-based Case Management Model Among ART-naive HIV-infected MSMWho this might be right forHIV/AIDS Sun Yat-sen University 600
Testing effectiveness (Phase 2)Study completedNCT00976404What this trial is testingTherapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral ReservoirWho this might be right forHIV Infection Robert L. Murphy 28
Post-approval studies (Phase 4)Study completedNCT01045369What this trial is testingA Pilot Study of Kaletra and Intelence Tablets in Naive SubjectsWho this might be right forHIV Infections Therapeutic Concepts 30
Not applicableStudy completedNCT02214173What this trial is testingThe Effect of an Enhanced Rice Bran Nutritional Supplement in HIVWho this might be right forHuman Immunodeficiency Virus Infection University of Miami 47
Not applicableUnknownNCT06019273What this trial is testingImpacts of Different ART Regimens on Lipid Metabolism in People Living With HIVWho this might be right forHIV InfectionCombined Antiretroviral Therapy First Affiliated Hospital of Zhejiang University 180
Not applicableStudy completedNCT00026754What this trial is testingEligibility Screening for the NIH Intramural Research Program Clinical ProtocolsWho this might be right forBreast CancerProstate CancerLung Cancer+2 more National Cancer Institute (NCI) 19,522
Large-scale testing (Phase 3)Study completedNCT00310973What this trial is testingHIV Prevention Within High-Risk Bulgarian and Hungarian Social NetworksWho this might be right forHIV Infections Medical College of Wisconsin 320
Not applicableStudy completedNCT00000873What this trial is testingA Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected InfantsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 2,400
Testing effectiveness (Phase 2)Study completedNCT00196586What this trial is testingEfficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsWho this might be right forHIV InfectionsChronic Hepatitis C French National Agency for Research on AIDS and Viral Hepatitis 75
Large-scale testing (Phase 3)Ended earlyNCT03333083What this trial is testingStudy With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current RegimenWho this might be right forHIV SeropositivityHIV InfectionsHIV-1-infection Judit Pich 17
Testing effectiveness (Phase 2)Study completedNCT00000641What this trial is testingA Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.Who this might be right forMycobacterium Avium-intracellulare InfectionHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT04303156What this trial is testingPharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)Who this might be right forHuman Immunodeficiency Virus (HIV) Infection Merck Sharp & Dohme LLC 12